Showing results (411-420 of 444) with videos related to

Sort By:
Pageof 45
Emerging Microbes & Infections|June 24, 2020
Epidemiology and clinical course of COVID-19 in Shanghai, ChinaYinzhong Shen, Fang Zheng, Danfeng Sun, et al.
Signal Transduction and Targeted Therapy|February 14, 2024
Asialoglycoprotein receptor 1 promotes SARS-CoV-2 infection of human normal hepatocytesXinyi Yang, Xu Zheng, Yuqi Zhu, et al.
Frontiers in Immunology|March 15, 2021
Epigenetic Landscapes of Single-Cell Chromatin Accessibility and Transcriptomic Immune Profiles of T Cells in COVID-19 PatientsShun Li, Bin Wu, Yun Ling, et al.
International Journal of Oncology|October 2, 2012
MUC1 glycopeptide epitopes predicted by computational glycomicsWei Song, Elizabeth S Delyria, Jieqing Chen, et al.
Nature|May 21, 2020
Viral and host factors related to the clinical outcome of COVID-19Xiaonan Zhang, Yun Tan, Yun Ling, et al.
The Journal of Infectious Diseases|May 17, 2017
IFITM3, TLR3, and CD55 Gene SNPs and Cumulative Genetic Risks for Severe Outcomes in Chinese Patients With H7N9/H1N1pdm09 InfluenzaNelson Lee, Bin Cao, Changwen Ke, et al.
Medical Mycology|September 23, 2022
Efficacy and safety of miconazole muco-adhesive tablet versus itraconazole in oropharyngeal candidiasis: A randomized, multi-centered, double-blind, phase 3 trialYufeng Wang, Haiwen Zhou, Wenmei Wang, et al.
Mbio|July 20, 2021
FKBP3 Induces Human Immunodeficiency Virus Type 1 Latency by Recruiting Histone Deacetylase 1/2 to the Viral Long Terminal RepeatXinyi Yang, Xiaying Zhao, Yuqi Zhu, et al.
Scientific Reports|June 18, 2017
Burden of sleep disturbances and associated risk factors: A cross-sectional survey among HIV-infected persons on antiretroviral therapy across ChinaXiaojie Huang, Huiqin Li, Kathrine Meyers, et al.
Cell Discovery|April 21, 2022
Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecovirusesYingdan Wang, Meiqin Liu, Yaping Shen, et al.
Pageof 45